Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension

Hieu T Ta1,2, Paul J Critser1,2, Michal Schäfer3

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Insights

Global ventricular function index (GFI) shows prognostic value in pediatric pulmonary hypertension (PH). This cardiac magnetic resonance imaging (CMR) metric predicts adverse outcomes, offering an advantage over traditional measures in PH patients.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Medical Imaging

Background:

  • Right ventricular (RV) metrics are crucial for prognostication in pulmonary hypertension (PH).
  • A global ventricular function index (GFI) derived from cardiac magnetic resonance imaging (CMR) has shown predictive value for adverse outcomes in adults.
  • GFI has not been previously evaluated in pediatric PH populations.

Purpose of the Study:

  • To assess the feasibility of using GFI as a predictor of composite adverse outcome (CAO) in pediatric PH patients.
  • To compare the predictive performance of GFI against traditional CMR-derived metrics.

Main Methods:

  • Retrospective chart review of pediatric PH patients who underwent CMR between January 2005 and June 2021.
  • Calculation of GFI (stroke volume divided by mean ventricular cavity and myocardial volume).
  • Definition of CAO as death, lung transplant, Potts shunt, or parenteral prostacyclin initiation; analysis using Cox proportional hazards regression.

Main Results:

  • The study included 89 pediatric PH patients; 24% experienced CAO.
  • Patients with CAO had significantly higher indexed RV volumes and mass, but lower ejection fraction (EF) and GFI.
  • Lower RV GFI (<43%) was associated with decreased event-free survival and increased CAO risk.
  • Multivariable models showed GFI improved CAO prediction compared to ventricular volumes, mass, or EF.

Conclusions:

  • RV GFI is a significant predictor of CAO in pediatric PH.
  • GFI offers enhanced prognostic value compared to traditional CMR markers like RV EF.
  • GFI is derived from readily available CMR data, requiring no additional post-processing, making it a potentially valuable clinical tool.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
231
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
375
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16